This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

Sponsored by Tabula Rasa HealthCare

About this trial

Last updated 3 years ago

Study ID

PGX-INITIATIVE-TRHC-2020-002

Status

Withdrawn

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 3 years ago

What is this trial about?

Tabula Rasa HealthCare (TRHC), doing business as CareKinesis, is the first national pharmacy that provides science-based medication risk identification and mitigation technologies and services. CareKinesis utilizes medication decision support tools and pharmacists certified in geriatrics to provide pharmacy services for various healthcare organizations including PACE organizations (described above). Presently, CareKinesis services more than 35 PACE organizations, including approximately 100 PACE sites, across the United States. As a national PACE pharmacy provider since 2011, CareKinesis focuses on improving medication regimens to reduce medication-related risks while enhancing economic, clinical and humanistic outcomes. Pharmacist-led PGx clinical services and medication safety reviews are currently being offered to PACE organizations under the direction of licensed healthcare prescribers by TRHC (CareKinesis). Our aim is to extend and meticulously study PGx testing for more PACE patients and conduct a prospective preemptive PGx study to determine feasibility of implementation and effect on outcomes. After mutual agreement, these services may also be extended to other organizations where TRHC provides pharmacy services, and data will be collected with patient consent.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients meeting all the following criteria will be included:

1. Patient is enrolled in a healthcare organization where TRHC provides pharmacy services during the implementation period;
2. Patient is able to understand, and provide informed consent to participate.
No

Exclusion Criteria

- Patients with one of the following criteria will be excluded:

1. Have taken an investigational product in the last 30 days;
2. Current use of illicit substances;
3. Any other medical, cognitive or physical abnormality, disease, or disorder that would prohibit the patient from completing study procedures in the judgement of the investigator and/or the prescriber.

Locations

Location

Status